Centre Hospitalier De Cayenne
- Address
- lock Available on a paid plan
Dermatology and Skin Health
Clinical research at Centre Hospitalier De Cayenne includes skin and connective tissue diseases, with a focus on acne in patients with skin of color. These studies are designed to compare treatment approaches and improve care for a common condition that can affect both appearance and quality of life.
- Testing whether an early acne treatment strategy offers better outcomes than standard care
- Improving management of moderate facial acne in skin of color patients
- Evaluating the effectiveness of a new therapeutic approach for reducing acne severity
This area of research reflects a broader interest in personalized treatment for dermatologic conditions and better support for underserved patient groups.
Oncology and Treatment Safety
The site is also involved in neoplasms research, especially for patients with gastrointestinal cancer receiving chemotherapy. The main goal is to improve treatment safety by adjusting care for people at higher risk of side effects.
- Studying ways to individualize chemotherapy for patients with gastrointestinal cancer
- Assessing strategies to reduce early treatment-related toxicity in DPD-deficient patients
- Supporting safer use of fluoropyrimidine-based cancer therapies
This research focuses on making cancer treatment more precise and better tolerated by adapting therapy to patient-specific biological factors.
Pediatric Hematology and Genetic Blood Disorders
Clinical trials at this hospital include work in hemic and lymphatic diseases, particularly sickle cell disease in young children. The studies aim to better understand how a treatment is handled by the body and to support safer, more effective care in pediatrics.
- Investigating sickle cell disease treatment in children from infancy to early childhood
- Building a pharmacokinetic model to better understand how the therapy is processed in the body
- Exploring treatment use in pediatric patients to support practical dosing guidance
This work contributes to improved treatment planning for children living with a chronic blood disorder.
Emergency Medicine and Acute Pain Care
The Service d’Accueil des Urgences – SAMU/SMUR also supports research in pathological conditions, signs and symptoms, with a focus on severe acute pain in the pre-hospital setting. These trials compare commonly used pain-relief options to help identify the most effective approach for urgent care.
- Comparing two intravenous pain treatments for rapid relief of severe acute pain
- Evaluating which option provides faster and better analgesic effect before hospital arrival
- Supporting decision-making in emergency response for adults in distress
This research is relevant to emergency teams seeking practical ways to improve comfort and treatment speed in urgent situations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 14 of 15 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier De Cayenne
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Cohort study of human mpox virus disease | University Of Oxford | Phase III | Not Recruiting | Aug 2022 | Jan 2024 |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Morphine Hydrochloride | 2 | Unknown | 2025-07-21 | 2025-07-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.